Login / Signup

Determining Optimal Cutoffs for Exhaled Carbon Monoxide and Salivary Cotinine to Identify Smokers among Korean Americans in a Smoking Cessation Clinical Trial.

Sun S KimSeongho KimPhilimon N Gona
Published in: Journal of smoking cessation (2021)
Exhaled CO and salivary cotinine are complementary, and they should be used together to verify smoking abstinence for smokers in a clinical trial.
Keyphrases
  • smoking cessation
  • clinical trial
  • replacement therapy
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial